Shaobo Xue

885 total citations · 1 hit paper
20 papers, 664 citations indexed

About

Shaobo Xue is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shaobo Xue has authored 20 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Shaobo Xue's work include Nanoplatforms for cancer theranostics (4 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (3 papers). Shaobo Xue is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (3 papers). Shaobo Xue collaborates with scholars based in China. Shaobo Xue's co-authors include Meiyu Bao, Han Lin, Zunzhen Ming, Huanhuan Zhu, Sujing Qiang, Weiwei Liu, Yu‐Shui Ma, Da Fu, Gai‐Xia Lu and Xinhai Ye and has published in prestigious journals such as Biomaterials, Chemical Engineering Journal and Molecular Cancer.

In The Last Decade

Shaobo Xue

19 papers receiving 659 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Living Bacterial Hydrogels for Accelerated Infected Wound Healing

2021 225 citations Zunzhen Ming, Han Lin et al. Advanced Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shaobo Xue China	12	289	136	135	111	109	20	664
Huan‐Tian Zhang China	21	481 1.7×	170 1.3×	117 0.9×	84 0.8×	156 1.4×	40	976
Gholamreza Tavoosidana Iran	13	428 1.5×	130 1.0×	138 1.0×	83 0.7×	115 1.1×	43	758
Ziba Veisi Malekshahi Iran	12	293 1.0×	149 1.1×	103 0.8×	77 0.7×	162 1.5×	28	612
Zhengang Zha China	20	341 1.2×	209 1.5×	129 1.0×	72 0.6×	204 1.9×	45	968
Yutong Wu China	19	507 1.8×	269 2.0×	266 2.0×	137 1.2×	110 1.0×	51	1.0k
Luo‐Qin Fu China	14	403 1.4×	235 1.7×	171 1.3×	78 0.7×	123 1.1×	31	1.0k
Shoujie Wang China	11	220 0.8×	158 1.2×	86 0.6×	107 1.0×	99 0.9×	34	567
Shuaiqiang Zhang China	9	279 1.0×	167 1.2×	111 0.8×	102 0.9×	135 1.2×	9	634
Chao Jian China	11	268 0.9×	224 1.6×	125 0.9×	55 0.5×	121 1.1×	15	662

Countries citing papers authored by Shaobo Xue

Since Specialization

Citations

This map shows the geographic impact of Shaobo Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaobo Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaobo Xue more than expected).

Fields of papers citing papers by Shaobo Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaobo Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaobo Xue. The network helps show where Shaobo Xue may publish in the future.

Co-authorship network of co-authors of Shaobo Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Shaobo Xue. A scholar is included among the top collaborators of Shaobo Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaobo Xue. Shaobo Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bian, Zhixuan, Chang Xu, Yue Zhang, et al.. (2025). WTAP participates in the DNA damage response via an m6A-FOXM1-dependent manner in hepatocellular carcinoma. Cell Death Discovery. 11(1). 397–397.

Bian, Zhixuan, Chang Xu, Baohua Zhang, et al.. (2024). TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular Carcinoma. Advanced Science. 11(35). e2402578–e2402578. 10 indexed citations

Liu, Ji, Libin Zou, Zhijin Zhang, et al.. (2024). Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8+ T cell activity in prostate cancer. Molecular Biomedicine. 5(1). 67–67. 1 indexed citations

Zhu, Huanhuan, Fei Gao, Yuan Li, et al.. (2024). MOF-based nanoparticles for tumor-targeted protein degradation and photodynamic therapy induce enhanced anti-tumor immunity. Nano Today. 56. 102308–102308. 11 indexed citations

Xue, Shaobo, et al.. (2024). A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review). International Journal of Oncology. 64(4). 5 indexed citations

Ma, Zhilong, et al.. (2023). Tumor Necrosis Factor Alpha Preconditioned Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Enhance the Inhibition of Necroptosis of Acinar cells in Severe Acute Pancreatitis. Tissue Engineering Part A. 29(23-24). 607–619. 6 indexed citations

Ming, Zunzhen, Han Lin, Meiyu Bao, et al.. (2023). An injectable antibacterial hydrogel to regulate ocular immune for endophthalmitis treatment. Chemical Engineering Journal. 465. 142889–142889. 13 indexed citations

Xue, Shaobo, et al.. (2023). AIE‐Active Glycomimetics Triggered Bacterial Agglutination and Membrane‐Intercalating toward Efficient Photodynamic Antiseptic. Advanced Healthcare Materials. 12(26). e2300818–e2300818. 10 indexed citations

Ma, Yu‐Shui, Sun Feng, Lan Lin, et al.. (2021). Protein disulfide isomerase inhibits endoplasmic reticulum stress response and apoptosis via its oxidoreductase activity in colorectal cancer. Cellular Signalling. 86. 110076–110076. 8 indexed citations

10.

Ming, Zunzhen, Han Lin, Meiyu Bao, et al.. (2021). Living Bacterial Hydrogels for Accelerated Infected Wound Healing. Advanced Science. 8(24). e2102545–e2102545. 225 indexed citations breakdown →

11.

Ma, Yu‐Shui, Xiaofeng Wang, Yunjie Zhang, et al.. (2020). Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency. Molecular Therapy — Oncolytics. 16. 147–157. 26 indexed citations

12.

Qiang, Sujing, Jie Zhou, Kesheng Wang, et al.. (2020). Knockout of farnesoid X receptor aggravates process of diabetic cardiomyopathy. Diabetes Research and Clinical Practice. 161. 108033–108033. 11 indexed citations

13.

Yan, Ning, Erik Jan Cornel, Haidong Cai, et al.. (2020). Bone-targeting polymer vesicles for simultaneous imaging and effective malignant bone tumor treatment. Biomaterials. 269. 120345–120345. 56 indexed citations

14.

Quan, Hui, Qiudan Chen, Kesheng Wang, et al.. (2020). Exendin-4 Reversed the PC12 Cell Damage Induced by circRNA CDR1as/miR-671/GSK3β Signaling Pathway. Journal of Molecular Neuroscience. 71(4). 778–789. 6 indexed citations

15.

Ma, Yu‐Shui, Zhijun Wu, Hongwei Zhang, et al.. (2019). Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM. Molecular Therapy — Oncolytics. 14. 172–178. 20 indexed citations

16.

Ma, Yu‐Shui, Fei Yu, Xiaoming Zhong, et al.. (2018). miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1. Molecular Therapy. 26(12). 2751–2765. 35 indexed citations

17.

Ma, Yu‐Shui, Huiqiong Yang, Shaobo Xue, et al.. (2018). Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma. Molecular Biology Reports. 45(6). 2615–2623. 40 indexed citations

18.

Ma, Yu‐Shui, Tao Huang, Xiaoming Zhong, et al.. (2018). Proteogenomic characterization and comprehensive integrative genomic analysis of human colorectal cancer liver metastasis. Molecular Cancer. 17(1). 139–139. 66 indexed citations

19.

Li, Zhong, Meiling Lü, Zaili Luo, et al.. (2015). Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis. OncoTargets and Therapy. 8. 1543–1543. 51 indexed citations

20.

Ye, Xinhai, et al.. (2014). Adipose-derived stem cells alleviate osteoporosis by enchancing osteogenesis and inhibiting adipogenesis in a rabbit model. Cytotherapy. 16(12). 1643–1655. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact